The Public Health Challenge of Δ8-THC and Derived Psychoactive Cannabis Products

Harlow et al found that 11% of US high school seniors (ie, 12th grade) reported using Δ8-tetrahdyrocannabinol (Δ8-THC) in the past 12 months based on a 2023 survey. This study is a reminder that there is a diverse set of cannabis products on the market that vary in their legal and regulatory status...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2024-03, Vol.331 (10), p.834-836
Hauptverfasser: Whitehill, Jennifer M, Dunn, Kelly E, Johnson, Renee M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Harlow et al found that 11% of US high school seniors (ie, 12th grade) reported using Δ8-tetrahdyrocannabinol (Δ8-THC) in the past 12 months based on a 2023 survey. This study is a reminder that there is a diverse set of cannabis products on the market that vary in their legal and regulatory status and potential for harm. Δ8-THC is a psychoactive cannabinoid that can be derived from hemp. It was introduced to the retail market in 2018 and there are indications that its use is on the rise. There is little regulatory oversight of production and sales of Δ8-THC and some evidence of adverse outcomes after use.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2024.0801